COLUMBIA, S.C., April 16, 2025 /PRNewswire/ -- Anticipating a rising need for individually wrapped vial medication manufacturing, The Ritedose Corporation, Inc. (Ritedose) is adding a seventh Syntegon ...
In Table 1, we describe six broad strategies that can be used to lower cancer drug dosing and reduce drug waste, many of which have already been clinically validated. Intravenous (IV) drug waste is ...
LONDON--(BUSINESS WIRE)--Market research firm Technavio has announced the release of their latest report on the global vials primary packaging market. This new report will provide expert market ...
Ritedose, a sterile contract manufacturing organisation, is expanding its manufacturing facility with a seventh Syntegon-branded packaging line. This expansion will effectively double the company's ...
Demand for sterile vials is growing steadily owing to increasing requirement from hybrid packaging solutions. With demand from clinical and compounding labs surging rapidly, manufacturers of sterile ...
New packaging line doubles Ritedose's capacity to package single, individually wrapped vial medications. The new Syntegon line will support Ritedose's ongoing manufacturing commitment for Verona ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback